Titlebook: Outcome Measures and Metrics in Systemic Lupus Erythematosus; Zahi Touma Book 2021 Springer Nature Switzerland AG 2021 Anxiety, depression

表被動(dòng)

Challenges and Advances in SLE Autoantibody Detection and Interpretation,..As an approach to limiting morbidity and rising healthcare costs associated with SLE, the future of ANA testing should focus on making an accurate and actionable diagnosis of very early SLE. To achieve this goal, harmonization of autoantibody testing and machine learning analytics will be important.

anesthesia

ASTER

Collected

Assessment of Depression and Anxiety in Lupus,es across studies of general population and rheumatic diseases, there are a lack of studies examining their use in SLE patients. Further research will be needed to develop consensus around disease-related cutoffs and to clarify the associations of disease- and patient-related factors in SLE.

圖表證明

Metrics and Outcomes of Systemic Lupus Erythematosus in Clinical Practice,es that recommend patient assessments using validated instruments of disease activity and validated disease damage metrics. We also provide an overview of several validated disease activity and damage metrics including the SLEDAI, SLAM, SLE-DAS, and BILAG.

coalition

c approach to the metrics utilized in the assessment of dise.Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that manifests with a myriad of clinical and laboratory features. The assessment of SLE is comprehensive and includes different core set domains; disease activity, damage,

FAZE

Introduction: Metrics and Domains Measured in SLE,h and clinical settings: disease activity, chronic damage resulting from lupus activity or its treatment, health-related quality of life (HRQoL), adverse events, and economic impact. Emerging concepts in SLE such as frailty are also introduced along with deep insights on selected existing concepts,

粗魯性質(zhì)

無(wú)孔

Tractable